Company: BIVIW
Filing Date: 2025-08-04
Form Type: S-1/A
Source: 0001520138-25-000235
Chunk: 145

Company: BIOVIE INC.
Filing Date: 2025-08-04
Form: S-1/A
Chunk 145
---
”)
(an ATM executed through a broker dealer as sales agent), and sole investment banker, sole book-runner and/or sole placement agent, at
the Representative’s sole discretion, for each and every future debt offering (such future public and private equity offering, a
“Future Transaction”), including all equity linked financings, during such twelve (12) month period for the Company, or any
successor to or any subsidiary of the Company, on reasonable and customary terms, provided a Future Transaction shall not be deemed to
include, and no Right of First Refusal is granted to the Representative in connection with, any of the following: (a) any equity securities
directly issued by the Company pursuant to acquisitions or strategic transactions, including as part of any grant funding from a third
party, or (b) any offer or sale of equity securities by the Company directly to non-U.S. persons domiciled in the following jurisdictions:
China, Korea, Latin America excluding Caribbean and the Cayman Islands) and Middle East, in each case, in a private placement not otherwise
involving a public offering. The Representative may elect, in its sole and absolute discretion, not to exercise its Right of First Refusal
with respect to any Future Transaction; provided that any such election by the Representative shall not adversely affect the Representative's
Right of First Refusal with respect to any other Future Transaction during the twelve (12) month period agreed to above.

<div align='center'>80</div>

Discretionary Accounts

The underwriters do not intend to confirm sales
of the Units and/or Pre-funded Units offered hereby to any accounts over which they have discretionary authority.

Electronic Distribution

This prospectus in electronic format may be made
available on websites or through other online services maintained by one or more of the underwriters, or by their affiliates. Other than
this prospectus in electronic format, the information on any underwriter’s website and any information contained in any other website
maintained by an underwriter is not part of this prospectus, has not been approved and/or endorsed by us or any underwriter in its capacity
as underwriter, and should not be relied upon by investors.

Nasdaq Capital Market Listing

Our Common Stock is listed on Nasdaq under the
symbol “BIVI”. We intend to apply to list the Warrants on Nasdaq under the symbol “BIVIW”. We cannot guarantee
that the Warrants will be approved for listing on Nasdaq. We do not intend to list